Pharmacological profile of antidepressants and related compounds at human monoamine transporters
about
Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disordersSelective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involvedA Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake InhibitorX-ray structure of dopamine transporter elucidates antidepressant mechanismInfluence of antidepressants on hemostasisAntidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structuresNeurotransmitter transporters and their impact on the development of psychopharmacologyImaging the serotonin transporter during major depressive disorder and antidepressant treatmentInhibition of acid sphingomyelinase by tricyclic antidepressants and analogonsStructural basis for action by diverse antidepressants on biogenic amine transportersNoradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episodeIncreased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysisTianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled studyPharmacological characterization of designer cathinones in vitroInhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort studyAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyAntidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control studyDuloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory studyExploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics StudyLeveraging a critical care database: selective serotonin reuptake inhibitor use prior to ICU admission is associated with increased hospital mortality.Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI ExposureHyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.The Concise Guide to PHARMACOLOGY 2013/14: transporters.Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disordersDisruption of aminergic signalling reveals novel compounds with distinct inhibitory effects on mosquito reproduction, locomotor function and survival.On the feasibility of designing new antidepressants.Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort studyA phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivorsA comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data.Role of the serotonergic system in reduced pulmonary function after exposure to methamphetamine.Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram.Selective serotonin reuptake inhibitors and gastrointestinal bleeding: a case-control study.Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors.Neuropharmacology of venlafaxine.A short update on the structure of drug binding sites on neurotransmitter transporters.
P2860
Q21129108-F636A524-A96F-495E-AA54-937C692FFF3DQ21129279-121C0241-BD22-4AF5-A513-8A2E92AB295EQ24563250-5C2E0B4F-B1ED-4FC5-A789-FE704E33A325Q24612997-399BAA81-092E-439D-B7D0-7B372816C4CDQ24635625-F640C91C-10F9-4F1D-B794-BBF959643D7CQ24655640-A98CAF06-9A5A-480F-B247-990A522B8E73Q24670273-85F39584-8059-47F0-B56D-2DF0C72C9E98Q24683135-EE421A2A-E294-4335-8B78-BC3D538CC005Q26852322-577D40E6-E02D-410F-9FF5-746BFEFC0E29Q27680298-45224DD7-B2C2-4992-84D6-5B348CAF3CE3Q28076943-9F438B07-A176-45D2-87A6-F78BFBB7598DQ28196269-AD7E9697-15DE-4317-B562-3F367E31A8DDQ28268467-C2FC7AF9-47FF-46EE-A21D-4129A801F088Q28273207-5263E2D6-B7DA-49DE-904C-73B6CF41625DQ28359696-125A4100-B844-4406-BFE2-B4A5410539D1Q28395248-5DDEC438-C606-48B1-843F-D4DCE805E530Q28478738-0276B110-80A7-44D5-BCD6-A7BD2ED67781Q28483370-5BF2F25D-1623-4784-8963-653C942B18B0Q28833274-92068368-E42D-43B4-AD74-98CA1E9C3985Q30406020-47A0F14A-E490-4DF8-8B0F-E1CFEDB159B6Q30443535-78DE2B2D-B8A4-4723-A40D-C5EF77A00C62Q30469931-C0B58697-FC8E-4C51-A548-27ACCDA32D40Q30475347-CA24FC74-086F-438D-8C7B-E6AD51021620Q30486743-DEB88552-9041-45D4-A30E-73F137723119Q30494212-937353F9-AA2A-4195-952B-015A51B5F306Q30582295-DE6395A7-966A-4582-B053-A11C59845E2EQ31116056-97F79831-1966-45EA-86BC-57C689E72242Q33488312-BD8891AB-66DD-4481-88E0-7498013A7378Q33634928-B0F25924-CCFB-411E-AD6A-F24B43ED0CFFQ33693343-3FE79C26-7A92-42B6-B854-83999F5D6C53Q33718185-02DE9B34-8915-4DDD-9A41-1196B21319F1Q33759011-5EAE28FB-92FB-41CD-9FE1-D5F069E1B88CQ33778302-B5C7E572-17D3-4A35-8E8B-F75C019FB42FQ33815059-1D997680-8794-4646-B7AF-5A9555A620C2Q33868543-EB0FF4C1-222E-49A7-886C-3CE6B3C1EFA3Q33897936-DB5BC485-134A-4465-85BE-CAA6788147E8Q33916845-1E87CAB0-778E-43C4-93B6-2D09D1019CC2Q33954811-08C01BAD-2169-4660-9FCA-6B5A369C8B3FQ34093686-D9BFC4DC-3718-4682-A88B-F2564D960B25Q34108966-07BA0F6F-862E-4124-9A51-D239EC0D5F86
P2860
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Pharmacological profile of ant ...... t human monoamine transporters
@ast
Pharmacological profile of ant ...... t human monoamine transporters
@en
Pharmacological profile of ant ...... t human monoamine transporters
@nl
type
label
Pharmacological profile of ant ...... t human monoamine transporters
@ast
Pharmacological profile of ant ...... t human monoamine transporters
@en
Pharmacological profile of ant ...... t human monoamine transporters
@nl
prefLabel
Pharmacological profile of ant ...... t human monoamine transporters
@ast
Pharmacological profile of ant ...... t human monoamine transporters
@en
Pharmacological profile of ant ...... t human monoamine transporters
@nl
P2093
P3181
P1476
Pharmacological profile of ant ...... t human monoamine transporters
@en
P2093
E Richelson
R D Blakely
P304
P3181
P356
10.1016/S0014-2999(97)01393-9
P407
P577
1997-12-11T00:00:00Z